Skip to main content
. 2020 Sep 25;60:103017. doi: 10.1016/j.ebiom.2020.103017

Table 1.

Patient characteristics of women according to their HPV status (hrHPV+ or hrHPV-). P values were calculated using a t-test for the age and a Fisher's exact test for disease status, ethnicity, parity, smoking, contraception and menopause. A P value < 0.05 was considered significant.

Patient Characteristics hrHPV+ (N = 65) hrHPV- (N = 65) P value
Age
Mean (SD, range) 36.6 (9.9, 25–69) 34.3 (7.9, 23–64) 0.139
Disease Status, n/N (%) <0.0001
Normal* /HPV 12/65 (18.5) 43/65 (66.2)
CIN1 13/65 (20.0) 17/65 (26.1)
CIN2 21/65 (32.3) 2/65 (3.1)
CIN3 14/65 (21.5) 3/65 (4.6)
Cancer 5/65 (7.7) 0/65 (0.0)
Ethnicity, n/N (%) 0.077
Caucasian 56/65 (86.2) 51/65 (78.5)
Asian 6/65 (9.2) 3/65 (4.6)
Black 3/65 (4.6) 7/65 (10.8)
Mixed⁎⁎ 0/65 (0.0) 4/65 (6.1)
Parity, n/N (%) 1.000
Nulliparous 46/65 (70.8) 48/65 (73.9)
Parous 16/65 (24.6) 17/65 (26.1)
Unknown 3/65 (4.6) 0/65 (0.0)
Smoking Status, n/N (%) 0.302
Current smoker 18/65 (27.7) 13/65 (20.0)
Non/Ex-smoker 44/65 (67.7) 52/65 (80.0)
Unknown 3/65 (4.6) 0/65 (0.0)
Contraception, n/N (%) 0.653
Nil 24/65 (36.9) 28/65 (43.1)
Condoms 12/65 (18.5) 11/65 (16.9)
COCP/POP 16/65 (24.6) 14/65 (21.5)
IUCD/IUD/Mirena/Contraceptive (injection/depot/implant/patch) 6/65 (9.2) 11/65 (16.9)
Unknown 7/65 (10.8) 1/65 (1.6)
Menopause, n/N (%) 0.719
Pre-menopausal 60/65 (92.3) 57/65 (87.7)
Post-menopausal 5/65 (7.7) 3/65 (4.6)
Unknown 0/65 (0.0) 5/65 (7.7)

Normal includes: diagnosis confirmed after histology (n = 32) and cytology (n = 17).

⁎⁎

Mixed includes: Afro-Caribbean/Irish; White African; Afro-Caribbean/British.